530313 — Kimia Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹3.23bn
- IN₹3.61bn
- IN₹1.19bn
- 76
- 24
- 81
- 67
Annual cashflow statement for Kimia Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 55.3 | -50.2 | -124 | -71.8 | 136 |
| Depreciation | |||||
| Non-Cash Items | 16.6 | 30.1 | 42.7 | 44.6 | 34.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -31.4 | 38.2 | -19.8 | 140 | 8.55 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 59.7 | 47.5 | -67.7 | 145 | 213 |
| Capital Expenditures | -136 | -35.8 | -28.1 | -15.1 | -46 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.419 | 28.7 | 0.134 | 0.135 | -1.02 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -136 | -7.1 | -28 | -14.9 | -47 |
| Financing Cash Flow Items | -24.8 | -33.5 | -27.6 | -35.5 | -57.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 79.9 | -44.3 | 95.4 | -131 | -166 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.55 | -3.82 | -0.272 | -0.301 | 0.585 |